Our AI-powered platform revolutionizes drug discovery, reducing time-to-market and increasing success rates for life-changing therapeutics.
Our comprehensive suite of AI-powered services accelerates every stage of the drug discovery pipeline, from target identification to lead optimization.
Screening large databases for compounds with high efficacy, synthetic accessibility, and drug-like properties.
Optimize lead compounds to enhance potency, reduce toxicity, and achieve an optimal pharmacokinetic profile.
Accurately predict absorption, distribution, metabolism, excretion, and toxicity profiles.
Our proprietary platform utilize AI, docking, and molecular dynamics simulations to overcome traditional drug discovery bottlenecks.
Predict compound biological activities using custom-developed models based on customers datasets using advanced machine learning algorithms.
Leverage our accurate models to predict key physicochemical and ADMET properties.
Leverage docking and molecular dynamics to accurately predict binding affinities and protein-ligand interactions.
Our platform has delivered measurable success across multiple therapeutic areas, accelerating drug discovery for our partners.
Highly accurate developed ADMET models
Predictions accuracy
Compounds used in training models
Peer-Reviewed Validation
Our technology has been validated in multiple publications in leading scientific journals including PLOS Digital Health and Journal of Computational Chemistry.
"To empower researchers and pharmaceutical industry by accelerating early-stage drug discovery using cutting-edge computational approaches."
"To become a trusted platform for computational drug discovery, bridging data, AI, and chemistry to design safer and more effective therapeutics faster than ever before."
Contact us to discuss how our AI-powered platform can accelerate your therapeutic programs and increase your chances of success.
Tailored approaches for your specific therapeutic area, target class, and discovery challenges.
Access to our cutting-edge AI models, molecular libraries, and expert scientific team.